|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/864 | (2006.01) |
| C07K 14/755 | (2013.01) | ||
| C07K 14/755 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| C12N2750/14143 | (2013.01) | ||
| A61P 7/04 | (2018.01) | ||
| C12N 15/62 | (2013.01) |
| (11) | Number of the document | 3652326 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18737622.3 |
| Date of filing the European patent application | 2018-07-10 | |
| (97) | Date of publication of the European application | 2020-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/068615 |
| Date | 2018-07-10 |
| (87) | Number | WO 2019/011893 |
| Date | 2019-01-17 |
| (30) | Number | Date | Country code |
| 17180601 | 2017-07-10 | EP |
| (72) |
NIJMEIJER, Bart Antonius , NL
FERREIRA, Valerie , NL
|
| (73) |
uniQure IP B.V. ,
Paasheuvelweg 25, 1105 BP Amsterdam,
NL
|
| (54) | MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS |
| MEANS AND METHODS FOR AAV GENE THERAPY IN HUMANS |